Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1160
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
American Drug Index
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 840
Book Description
Monographs provide manufacturer, generic name, preparation and size availability. Also includes chapters on container and storage requirements, dosage forms that should not be crushed, and a list of distributors.
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 840
Book Description
Monographs provide manufacturer, generic name, preparation and size availability. Also includes chapters on container and storage requirements, dosage forms that should not be crushed, and a list of distributors.
Drug Literature
Author: United States. Congress. Senate. Committee on Government Operations. Subcommittee on Reorganization and Internal Organizations
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 194
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 194
Book Description
American Book Publishing Record Cumulative, 1950-1977
Author: R.R. Bowker Company. Department of Bibliography
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 1454
Book Description
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 1454
Book Description
Drug Information Sources
Author: Moshe Mangad
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 116
Book Description
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 116
Book Description
Interagency Coordination in Drug Research and Regulation
Author: United States. Congress. Senate. Committee on Government Operations. Subcommittee on Reorganization and International Organizations
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 2010
Book Description
Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use.
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 2010
Book Description
Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use.
National Library of Medicine Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 910
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 910
Book Description
NIH Library Booklist
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 900
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 900
Book Description
Interagency Coordination in Drug Research and Regulation
Author: United States. Congress. Senate. Committee on Government Operations
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 356
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 356
Book Description
Hearings, Reports and Prints of the Senate Committee on Government Operations
Author: United States. Congress. Senate. Committee on Government Operations
Publisher:
ISBN:
Category : Executive departments
Languages : en
Pages : 1158
Book Description
Publisher:
ISBN:
Category : Executive departments
Languages : en
Pages : 1158
Book Description